$135.72
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Teleflex, Inc. engages in the provision of medical technology products. The company is headquartered in Wayne, Pennsylvania and currently employs 15,500 full-time employees. The firm offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
Country

US

CEO

Mr. Stuart Randle

IPO date

1980

Employees

15,500

ISIN

US8793691069

Key stats

Open

$135.57

Volume

531.47K

Market cap

$5.93B

Prev. close

$134.04

Impl / hst vl

-

Open interest

$0.00

$134.31

Day’s Range

$137.08

$101.01

52W Range

$139.67

Valuation

44
Valuation score
Fairly Valued
P/E
-
P/S
2.10
P/B
1.92
Current ratio
2.55
Debt / Equity
0.75
ROE
-28.27%
Gross margin
56.07%
Income growth
-98.86%
FCF growth
-80.05

Jun

30

Dividends

The last payment date was Jun 30, 2026

Div. per Share

$0.34

Div. Yield

0.25%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Hold

The average rating from top 10 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$146.63
The top 12 analysts forecasts that 12-month price may increase by 8.04%, with a low of $125.80 and a high of $168.00
$125.80
Low
$146.63
Avg
$168.00
High
Current price

Earnings

Q1 ‘26 revenue
$548.26M
Q1 ‘26 net income
-$8.15M
Revenue
Net income
Previous EPS
$1.39
Estimate EPS
$1.28
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply